n-methyl-3,4-methylenedioxyamphetamine has been researched along with dopamine quinone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boxler, MI; Kraemer, T; Steuer, AE; Stock, L | 1 |
1 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and dopamine quinone
Article | Year |
---|---|
Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine.
Topics: Catechol O-Methyltransferase; Chromatography, Liquid; Deamination; Dopamine; Humans; Inhibitory Concentration 50; Monoamine Oxidase; Monoamine Oxidase Inhibitors; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Reactive Oxygen Species; Serotonin; Tandem Mass Spectrometry | 2016 |